|
The newsletter is
not displayed correctly? Please click here.
Newsletter 6/2010
8
April 2010
[gs]
Abbott –
Shopping All Over the Place
or: Corporate
Strategy, revisited
If you do not
wish to receive this newsletter anymore, just reply to this mail
without any comment and you will be taken off the mailing list.
-----------------------------
Dear
reader,
just
last month Abbott started a cash tender offer for Facet Biotech; a company Biogen Idec tried to acquire before with
an unsuccessful, unfriendly bid.
This latest acquisition
of Abbott is the last "pearl" in a string of deals that maybe really
started with Abbott’s acquisition of Guidant’s
vascular business announced back in January 2006
Abbott.
(1/8/06). "Press Release: Abbott to Acquire Guidant Vascular Business
Contingent Upon Close of Boston Scientific's Proposed Acquisition of
Guidant". Abbott Park, IL....
The
news of further acquisitions by Abbott became more
interesting and interesting ever since that acquisition.
-----------------------------------------------------------------------------------
Recent
Acquisitions by Abbott
------------------------------
Isis
Pharmaceuticals, Inc.. (12/17/08). "Press Release: Abbott Exercises Its
Option to Acquire Ibis Biosciences, a Subsidiary of Isis. Total
Acquisition Price Will Be $215 Million. Acquisition Will Expand
Abbott’s Position in Molecular Diagnostics for In
Abbott.
(1/26/09). "Press Release: Abbott to Commence Tender Offer on Jan. 27
for all Outstanding Shares of Advanced Medical Optics, Inc.". Abbott
Park, IL.
Abbott.
(9/2/09). "Press Release: Abbott to Acquire Visiogen, Expanding Vision
Care Portfolio. Provides Abbott with Next-generation Cataract
Technology to Address Presbyopia". Abbott Park, IL & Irvine, CA.
Abbott.
(9/10/09). "Press Release: Abbott to Acquire Evalve, Inc., a Leader in
Minimally Invasive Cardiac Valve Repair Technology. Acquisition Expands
Vascular Portfolio, Provides Abbott with Global Leadership Position in
Non-surgical Treatment Option".
Abbott.
(9/28/09). "Press Release: Abbott to Acquire Solvay Pharmaceuticals
Business. Diversifies Abbott’s Pharmaceutical Products,
Expanding International Growth Platform – Supports Long-term
Strategy to Bolster Presence in Key Global Emerging Markets".
Abbott.
(12/14/09). "Press Release: Abbott to Acquire STARLIMS Technologies
Ltd., a Leader in Laboratory Information Management Systems". Abbott
Park, IL & Hollywood, FL.
Abbott.
(3/9/10). "Press Release: Abbott Enhances Pharmaceutical Pipeline with
Acquisition of Facet Biotech". Abbott Park, IL & Redwood City,
CA.
-----------------------------------------------------------------------------------
But even before there have been many acquisitions by Abbott, including the major 6.9 billion
dollar acquisition of BASF Pharma back in 2001:
------------------------------
Please
note: details for the links below are only available to [gs]
subscribers. Contact me for a subscription!
------------------------------
Prior Acquisitions by Abbott
Kos
Pharmaceuticals–Abbott: investment, 200611–200612
acquisition $3.7b net of cash in cash
Therasense–Abbott:
investment, 200402c–200404 acqu $1.2b
Spinal
Concepts–Abbott: investment, 200306– acqu announced
$170m in cash + up to $40m milestones
Vysis–Abbott:
investment, 200110 acquisition $355m
and finally the above mentioned acquisition of BASF Pharma
BASF–Abbott:
investment, 200012–2001 BASF Pharma acquisition $6.9b
The Abbott Strategy
In my view, the recent strategy of Abbott is unique in the whole health
care industry as the company buys assets in a diverse range of
technologies (from biologicals to generics, from molecular diagnostics
to medical devices and now even LIMS) and in many different indication
areas.
It will be interesting to watch who will be next on Abbott’s
list and how this strategy will finally work out. In the end it will
depend on
– the financial muscle of Abbott,
– the fast and successful integration of all those
businesses, and ultimately
– the question whether there are enough synergies to justify
this broad approach.
Finally, here come some interesting details related to the Abbott story
Did you know, that...
... Abbott tried unsuccessfully to sell its core
laboratory and poin-of-care diagnostics business to General Electric?
Abbott.
(7/11/07). "Press Release: Abbott Announces Termination of Contract
with GE". Abbott Park, IL.
... Solvay Pharmaceuticals recently acquired
Innogenetics?
Innogenetics–Solvay:
investment, 200804–200812 cash tender offer €177.6m
for all outstanding shares €5.75/share Solvay Pharmaceuticals
SA
... the origin of Facet Biotech Corporation?
PDL
BioPharma, Inc.. (11/6/08). "Press Release: PDL BioPharma Appoints John
P. McLaughlin to Become President and CEO Upon Completion of Spin-off
of Biotechnology Assets". Redwood City, CA....
-----------------------------------------------------------------------------------
Okay, that’s all for today.
Thanks
for reading, back in 14 days!
Marcus
Lippold
-----------------------------------------------------------------------------------
©2010 by
[iito] Business Intelligence
NOTES & DISCLAIMER
Some links are available to subscribers
only. As this
newsletter is a free service, available to anybody without a
contractual
agreement, the writer disclaims any liabilities and explicitly advises
you, not to use this information for your own business
decisions.
I hope you enjoy reading these lines as much as I have enjoyed writing
them!
Thank you.
Marcus Lippold
Dipl.-Oek. (Economist)
[iito] Business Intelligence
Parkallee 24
28209 Bremen
Germany
Phone +49(0)-421-62659 196
Fax +49(0)-700-4-367-367-6
E-mail mlippold@iito.de
Web www.iito.de
This
communication is confidential. If you are not the intended recipient,
you should not copy or disclose the message to anyone, but should
kindly
notify the sender and delete the message.
|
